[1]
Ernst ME, Fravel MA. Thiazide and the Thiazide-Like Diuretics: Review of Hydrochlorothiazide, Chlorthalidone, and Indapamide. American journal of hypertension. 2022 Jul 1:35(7):573-586. doi: 10.1093/ajh/hpac048. Epub
[PubMed PMID: 35404993]
[2]
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension (Dallas, Tex. : 1979). 2018 Jun:71(6):e13-e115. doi: 10.1161/HYP.0000000000000065. Epub 2017 Nov 13
[PubMed PMID: 29133356]
Level 1 (high-level) evidence
[3]
HOLLANDER W, WILKINS RW. Chlorothiazide: a new type of drug for the treatment of arterial hypertension. BMQ; the Boston medical quarterly. 1957 Sep:8(3):69-75
[PubMed PMID: 13471453]
[4]
Ojji DB, Mayosi B, Francis V, Badri M, Cornelius V, Smythe W, Kramer N, Barasa F, Damasceno A, Dzudie A, Jones E, Mondo C, Ogah O, Ogola E, Sani MU, Shedul GL, Shedul G, Rayner B, Okpechi IG, Sliwa K, Poulter N, CREOLE Study Investigators. Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans. The New England journal of medicine. 2019 Jun 20:380(25):2429-2439. doi: 10.1056/NEJMoa1901113. Epub 2019 Mar 18
[PubMed PMID: 30883050]
[5]
Sica DA, Carter B, Cushman W, Hamm L. Thiazide and loop diuretics. Journal of clinical hypertension (Greenwich, Conn.). 2011 Sep:13(9):639-43. doi: 10.1111/j.1751-7176.2011.00512.x. Epub 2011 Jul 27
[PubMed PMID: 21896142]
[6]
Dhayat NA, Bonny O, Roth B, Christe A, Ritter A, Mohebbi N, Faller N, Pellegrini L, Bedino G, Venzin RM, Grosse P, Hüsler C, Koneth I, Bucher C, Del Giorno R, Gabutti L, Mayr M, Odermatt U, Buchkremer F, Ernandez T, Stoermann-Chopard C, Teta D, Vogt B, Roumet M, Tamò L, Cereghetti GM, Trelle S, Fuster DG. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. The New England journal of medicine. 2023 Mar 2:388(9):781-791. doi: 10.1056/NEJMoa2209275. Epub
[PubMed PMID: 36856614]
[7]
Kim GH, Lee JW, Oh YK, Chang HR, Joo KW, Na KY, Earm JH, Knepper MA, Han JS. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel. Journal of the American Society of Nephrology : JASN. 2004 Nov:15(11):2836-43
[PubMed PMID: 15504936]
[8]
Earley LE, Orloff J. THE MECHANISM OF ANTIDIURESIS ASSOCIATED WITH THE ADMINISTRATION OF HYDROCHLOROTHIAZIDE TO PATIENTS WITH VASOPRESSIN-RESISTANT DIABETES INSIPIDUS. The Journal of clinical investigation. 1962 Nov:41(11):1988-97
[PubMed PMID: 16695887]
[9]
Hierholzer K, Wiederholt M. Some aspects of distal tubular solute and water transport. Kidney international. 1976 Feb:9(2):198-213
[PubMed PMID: 940262]
[10]
Subramanya AR, Ellison DH. Distal convoluted tubule. Clinical journal of the American Society of Nephrology : CJASN. 2014 Dec 5:9(12):2147-63. doi: 10.2215/CJN.05920613. Epub 2014 May 22
[PubMed PMID: 24855283]
[11]
Cheng L, Poulsen SB, Wu Q, Esteva-Font C, Olesen ETB, Peng L, Olde B, Leeb-Lundberg LMF, Pisitkun T, Rieg T, Dimke H, Fenton RA. Rapid Aldosterone-Mediated Signaling in the DCT Increases Activity of the Thiazide-Sensitive NaCl Cotransporter. Journal of the American Society of Nephrology : JASN. 2019 Aug:30(8):1454-1470. doi: 10.1681/ASN.2018101025. Epub 2019 Jun 28
[PubMed PMID: 31253651]
[12]
Yin J,Wagner DJ,Prasad B,Isoherranen N,Thummel KE,Wang J, Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K. American journal of physiology. Renal physiology. 2019 Oct 1;
[PubMed PMID: 31322418]
[13]
Beermann B, Groschinsky-Grind M. Pharmacokinetics of hydrochlorothiazide in man. European journal of clinical pharmacology. 1977 Dec 2:12(4):297-303
[PubMed PMID: 590315]
[14]
Sinha AD, Agarwal R. Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD. Clinical journal of the American Society of Nephrology : CJASN. 2019 May 7:14(5):757-764. doi: 10.2215/CJN.04330418. Epub 2018 Nov 13
[PubMed PMID: 30425103]
[15]
Rapoport RM, Soleimani M. Mechanism of Thiazide Diuretic Arterial Pressure Reduction: The Search Continues. Frontiers in pharmacology. 2019:10():815. doi: 10.3389/fphar.2019.00815. Epub 2019 Aug 27
[PubMed PMID: 31543812]
[16]
Duarte JD, Cooper-DeHoff RM. Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert review of cardiovascular therapy. 2010 Jun:8(6):793-802. doi: 10.1586/erc.10.27. Epub
[PubMed PMID: 20528637]
[17]
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3:145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1
[PubMed PMID: 35363499]
Level 1 (high-level) evidence
[18]
Vaz de Castro PAS, Bitencourt L, de Oliveira Campos JL, Fischer BL, Soares de Brito SBC, Soares BS, Drummond JB, Simões E Silva AC. Nephrogenic diabetes insipidus: a comprehensive overview. Journal of pediatric endocrinology & metabolism : JPEM. 2022 Apr 26:35(4):421-434. doi: 10.1515/jpem-2021-0566. Epub 2022 Feb 11
[PubMed PMID: 35146976]
Level 3 (low-level) evidence
[19]
Arrabal-Martín M, González-Torres S, Cano-García MD, De Haro-Muñoz T, Abad-Menor F, Arrabal-Polo MÁ, Cózar-Olmo JM. Urine Calcium and Bone Mineral Density in Calcium Stone-Forming Patients Treated with Alendronate and Hydrochlorothiazide. Urologia internationalis. 2016:97(3):292-298
[PubMed PMID: 26800461]
[20]
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension (Dallas, Tex. : 1979). 2018 Jun:71(6):1269-1324. doi: 10.1161/HYP.0000000000000066. Epub 2017 Nov 13
[PubMed PMID: 29133354]
Level 1 (high-level) evidence
[21]
Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ, ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. The New England journal of medicine. 2008 Dec 4:359(23):2417-28. doi: 10.1056/NEJMoa0806182. Epub
[PubMed PMID: 19052124]
[22]
Palmer BF. Metabolic complications associated with use of diuretics. Seminars in nephrology. 2011 Nov:31(6):542-52. doi: 10.1016/j.semnephrol.2011.09.009. Epub
[PubMed PMID: 22099511]
[23]
Zhang X, Zhao Q. Association of Thiazide-Type Diuretics With Glycemic Changes in Hypertensive Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. Journal of clinical hypertension (Greenwich, Conn.). 2016 Apr:18(4):342-51. doi: 10.1111/jch.12679. Epub 2015 Sep 23
[PubMed PMID: 26395424]
Level 1 (high-level) evidence
[24]
Choi HK, Soriano LC, Zhang Y, Rodríguez LA. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ (Clinical research ed.). 2012 Jan 12:344():d8190. doi: 10.1136/bmj.d8190. Epub 2012 Jan 12
[PubMed PMID: 22240117]
Level 2 (mid-level) evidence
[25]
Price AL, Lingvay I, Szczepaniak EW, Wiebel J, Victor RG, Szczepaniak LS. The metabolic cost of lowering blood pressure with hydrochlorothiazide. Diabetology & metabolic syndrome. 2013 Jul 9:5(1):35. doi: 10.1186/1758-5996-5-35. Epub 2013 Jul 9
[PubMed PMID: 23837919]
[26]
Sullivan TJ. Cross-reactions among furosemide, hydrochlorothiazide, and sulfonamides. JAMA. 1991 Jan 2:265(1):120-1
[PubMed PMID: 1984112]
[27]
Chen SH, Karanjia R, Chevrier RL, Marshall DH. Bilateral acute angle closure glaucoma associated with hydrochlorothiazide-induced hyponatraemia. BMJ case reports. 2014 Dec 4:2014():. doi: 10.1136/bcr-2014-206690. Epub 2014 Dec 4
[PubMed PMID: 25477363]
Level 3 (low-level) evidence
[28]
Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology (Baltimore, Md.). 2013 Apr:57(4):1651-3. doi: 10.1002/hep.26359. Epub
[PubMed PMID: 23463403]
Level 1 (high-level) evidence
[29]
Jo W, Koh ES, Chung S. Therapeutic roles of thiazides and loop diuretics in blood pressure control and renal protection against chronic kidney disease. Clinical hypertension. 2023 May 15:29(1):14. doi: 10.1186/s40885-023-00238-5. Epub 2023 May 15
[PubMed PMID: 37183259]
[30]
Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2016 Feb:101(2):364-89. doi: 10.1210/jc.2015-1710. Epub 2016 Jan 13
[PubMed PMID: 26760044]
Level 1 (high-level) evidence
[31]
Pedersen SA, Gaist D, Schmidt SAJ, Hölmich LR, Friis S, Pottegård A. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. Journal of the American Academy of Dermatology. 2018 Apr:78(4):673-681.e9. doi: 10.1016/j.jaad.2017.11.042. Epub 2017 Dec 4
[PubMed PMID: 29217346]
Level 2 (mid-level) evidence
[32]
Pottegård A, Hallas J, Olesen M, Svendsen MT, Habel LA, Friedman GD, Friis S. Hydrochlorothiazide use is strongly associated with risk of lip cancer. Journal of internal medicine. 2017 Oct:282(4):322-331. doi: 10.1111/joim.12629. Epub 2017 Jun 6
[PubMed PMID: 28480532]
[33]
Novak JE, Ellison DH. Diuretics in States of Volume Overload: Core Curriculum 2022. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2022 Aug:80(2):264-276. doi: 10.1053/j.ajkd.2021.09.029. Epub 2022 Feb 19
[PubMed PMID: 35190215]
[34]
Ishani A, Cushman WC, Leatherman SM. Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. Reply. The New England journal of medicine. 2023 Apr 6:388(14):1342. doi: 10.1056/NEJMc2301922. Epub
[PubMed PMID: 37018506]